Try it
ENT · Larynx and airway: mitomycin C in airway stenosis
Sample itemAfter endoscopic dilatation of a subglottic stenosis, the surgeon applies mitomycin C topically to the scar. What is its aim?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. To inhibit fibroblast proliferation and reduce restenosis
Mitomycin C is an alkylating agent that inhibits fibroblast proliferation and collagen synthesis. Applied briefly to the dilated or resected scar, it aims to reduce recurrence of stenosis, though evidence of benefit is mixed.
Option by option
A. To promote epithelial growth over the raw area
It does not stimulate epithelial growth; it slows the proliferation of connective tissue cells.
B. To increase collagen cross-linking in the scar
Increasing collagen cross-linking would strengthen the scar and promote contraction.
C. To inhibit fibroblast proliferation and reduce restenosis (correct)
Correct. Mitomycin C inhibits fibroblast proliferation and so limits scarring and restenosis.
D. To provide broad-spectrum antibacterial cover
Mitomycin C is a cytotoxic antibiotic used for its antiproliferative effect, not as antibacterial cover.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More ENT questions
- AudiologyIn a tuning fork test, Rinne is negative (bone conduction louder than air conduction) in…
- EarWhich type of chronic suppurative otitis media is considered 'unsafe'?
- LarynxIn singers, vocal nodules typically occur at:
- Vestibular disordersA patient has recurrent attacks of vertigo lasting hours, with fluctuating low-frequency…